JP2014505062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505062A5 JP2014505062A5 JP2013550865A JP2013550865A JP2014505062A5 JP 2014505062 A5 JP2014505062 A5 JP 2014505062A5 JP 2013550865 A JP2013550865 A JP 2013550865A JP 2013550865 A JP2013550865 A JP 2013550865A JP 2014505062 A5 JP2014505062 A5 JP 2014505062A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide according
- treatment
- scars
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 206010052428 Wound Diseases 0.000 claims 5
- 208000027418 Wounds and injury Diseases 0.000 claims 5
- 208000032544 Cicatrix Diseases 0.000 claims 3
- 206010061218 Inflammation Diseases 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 231100000241 scar Toxicity 0.000 claims 3
- 230000037387 scars Effects 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- QFQYGJMNIDGZSG-YFKPBYRVSA-N (2r)-3-(acetamidomethylsulfanyl)-2-azaniumylpropanoate Chemical group CC(=O)NCSC[C@H]([NH3+])C([O-])=O QFQYGJMNIDGZSG-YFKPBYRVSA-N 0.000 claims 1
- 206010002515 Animal bite Diseases 0.000 claims 1
- 206010007247 Carbuncle Diseases 0.000 claims 1
- 208000032840 Catheter-Related Infections Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 201000000297 Erysipelas Diseases 0.000 claims 1
- 206010017553 Furuncle Diseases 0.000 claims 1
- 206010021531 Impetigo Diseases 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 208000031650 Surgical Wound Infection Diseases 0.000 claims 1
- 238000005299 abrasion Methods 0.000 claims 1
- 206010000269 abscess Diseases 0.000 claims 1
- 208000002029 allergic contact dermatitis Diseases 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 201000010653 vesiculitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11152213A EP2481751A1 (en) | 2011-01-26 | 2011-01-26 | Human lactoferrin derived peptides |
| EP11152213.2 | 2011-01-26 | ||
| PCT/EP2012/051112 WO2012101157A1 (en) | 2011-01-26 | 2012-01-25 | Human lactoferrin derived peptides and there use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505062A JP2014505062A (ja) | 2014-02-27 |
| JP2014505062A5 true JP2014505062A5 (enExample) | 2015-02-26 |
| JP6158713B2 JP6158713B2 (ja) | 2017-07-05 |
Family
ID=44123487
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550864A Expired - Fee Related JP6158712B2 (ja) | 2011-01-26 | 2012-01-25 | 新規合成ペプチド及びそれらの使用 |
| JP2013550865A Expired - Fee Related JP6158713B2 (ja) | 2011-01-26 | 2012-01-25 | ヒトラクトフェリン由来ペプチド及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550864A Expired - Fee Related JP6158712B2 (ja) | 2011-01-26 | 2012-01-25 | 新規合成ペプチド及びそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9132165B2 (enExample) |
| EP (3) | EP2481751A1 (enExample) |
| JP (2) | JP6158712B2 (enExample) |
| KR (2) | KR101933900B1 (enExample) |
| CN (2) | CN103476792B (enExample) |
| AU (2) | AU2012210564B2 (enExample) |
| BR (2) | BR112013018365A2 (enExample) |
| CA (2) | CA2825247A1 (enExample) |
| ES (2) | ES2633353T3 (enExample) |
| MX (2) | MX341020B (enExample) |
| PL (1) | PL2668205T3 (enExample) |
| RU (2) | RU2593757C2 (enExample) |
| WO (2) | WO2012101157A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2481751A1 (en) * | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
| GB201401877D0 (en) * | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
| CN104888202A (zh) * | 2014-05-22 | 2015-09-09 | 闫牧乔 | 一种治疗扁桃体炎的药物 |
| IT201800002457A1 (it) * | 2018-02-07 | 2019-08-07 | Neilos S R L | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie |
| RU2681216C1 (ru) * | 2018-09-05 | 2019-03-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala |
| RU2681310C1 (ru) * | 2018-09-05 | 2019-03-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala |
| WO2020096672A1 (en) | 2018-11-09 | 2020-05-14 | The Wistar Institute Of Anatomy And Biology | Use of lactoferrin for generating myeloid-derived suppressor cells |
| KR102032945B1 (ko) * | 2018-12-03 | 2019-10-16 | 순천대학교 산학협력단 | 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물 |
| NL2024839B1 (en) * | 2020-02-05 | 2021-09-13 | Cbmr Scient Nanoscience B V | Antimicrobial peptide for treatment and controlling skin disorders relating to microbial infection |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2818056B2 (ja) | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
| AU665381B2 (en) | 1992-01-23 | 1996-01-04 | Morinaga Milk Industry Company Limited | Antibacterial agent and treatment of article therewith |
| JP3347819B2 (ja) | 1993-06-28 | 2002-11-20 | 森永乳業株式会社 | 抗菌性ペプチドの精製方法 |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| JP3529423B2 (ja) | 1994-04-01 | 2004-05-24 | 森永乳業株式会社 | 抗菌性ペプチドの製造方法 |
| JP3812957B2 (ja) | 1994-08-02 | 2006-08-23 | 森永乳業株式会社 | 角膜損傷治療剤 |
| JPH08143468A (ja) | 1994-11-17 | 1996-06-04 | Morinaga Milk Ind Co Ltd | 抗潰瘍剤 |
| JP2001504447A (ja) | 1996-08-12 | 2001-04-03 | エイプラス サイエンス インベスト アーベー | ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防 |
| US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| SE9804614A0 (en) * | 1998-07-06 | 2000-01-07 | A+ Science Invest Ab | New peptides and use thereof |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| AU5010800A (en) * | 1999-05-14 | 2000-12-05 | Regents Of The University Of California, The | Anti-inflammatory therapy for inflammatory mediated infection |
| CA2388910C (en) | 1999-11-11 | 2008-10-07 | Am-Pharma B.V. | Antimicrobial activity of the first cationic cluster of human lactoferrin |
| RU2165769C1 (ru) * | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
| SE0102067D0 (sv) * | 2001-06-11 | 2001-06-11 | A & Science Invest Ab | Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation |
| WO2006047744A2 (en) | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
| EP2078529B1 (en) * | 2006-07-10 | 2014-12-10 | PBA3 Biomed GmbH | Antimicrobial peptides |
| JP5444544B2 (ja) * | 2007-02-09 | 2014-03-19 | ジェノミディア株式会社 | 血管新生誘導剤及びそれに用いられるポリペプチド |
| JP5384948B2 (ja) * | 2007-02-09 | 2014-01-08 | ジェノミディア株式会社 | 新規ポリペプチド及びそれを有効成分として含有する抗菌剤 |
| EP2050461A1 (en) | 2007-10-19 | 2009-04-22 | PharmaSurgics in Sweden AB | Peptides based on the sequence of human lactoferrin and their use |
| EP2060586A1 (en) * | 2007-11-14 | 2009-05-20 | PharmaSurgics in Sweden AB | New synthetic arginine substituted peptides and their use |
| PT2277890E (pt) * | 2008-05-23 | 2016-03-31 | Daiichi Sankyo Co Ltd | Péptido capaz de prolongar o semi-período de vida do péptido de interesse no plasma |
| ES2400466T3 (es) * | 2009-01-13 | 2013-04-10 | Pergamum Ab | Composiciones que contienen ácido hialurónico para el tratamiento de heridas, cicatrices y la formación de adherencias postquirúrgicas |
| EP2481751A1 (en) * | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
| KR101341210B1 (ko) * | 2013-01-24 | 2013-12-12 | 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 | 신규한 항균 펩타이드 및 이의 용도 |
-
2011
- 2011-01-26 EP EP11152213A patent/EP2481751A1/en not_active Withdrawn
-
2012
- 2012-01-25 EP EP12700715.1A patent/EP2668204B1/en not_active Not-in-force
- 2012-01-25 WO PCT/EP2012/051112 patent/WO2012101157A1/en not_active Ceased
- 2012-01-25 CN CN201280006521.7A patent/CN103476792B/zh not_active Expired - Fee Related
- 2012-01-25 JP JP2013550864A patent/JP6158712B2/ja not_active Expired - Fee Related
- 2012-01-25 PL PL12701866T patent/PL2668205T3/pl unknown
- 2012-01-25 ES ES12701866.1T patent/ES2633353T3/es active Active
- 2012-01-25 KR KR1020137021856A patent/KR101933900B1/ko not_active Expired - Fee Related
- 2012-01-25 CA CA2825247A patent/CA2825247A1/en not_active Abandoned
- 2012-01-25 MX MX2013007995A patent/MX341020B/es active IP Right Grant
- 2012-01-25 JP JP2013550865A patent/JP6158713B2/ja not_active Expired - Fee Related
- 2012-01-25 BR BR112013018365A patent/BR112013018365A2/pt not_active IP Right Cessation
- 2012-01-25 KR KR1020137021855A patent/KR101949210B1/ko not_active Expired - Fee Related
- 2012-01-25 US US13/981,609 patent/US9132165B2/en not_active Expired - Fee Related
- 2012-01-25 BR BR112013018264A patent/BR112013018264A2/pt not_active IP Right Cessation
- 2012-01-25 AU AU2012210564A patent/AU2012210564B2/en not_active Ceased
- 2012-01-25 US US13/981,614 patent/US8846608B2/en active Active
- 2012-01-25 AU AU2012210565A patent/AU2012210565B2/en not_active Expired - Fee Related
- 2012-01-25 WO PCT/EP2012/051111 patent/WO2012101156A2/en not_active Ceased
- 2012-01-25 RU RU2013139302/04A patent/RU2593757C2/ru active
- 2012-01-25 CA CA2825246A patent/CA2825246A1/en not_active Abandoned
- 2012-01-25 RU RU2013139294/10A patent/RU2596393C2/ru active
- 2012-01-25 ES ES12700715.1T patent/ES2645959T3/es active Active
- 2012-01-25 MX MX2013008530A patent/MX342313B/es active IP Right Grant
- 2012-01-25 EP EP12701866.1A patent/EP2668205B1/en not_active Not-in-force
- 2012-01-25 CN CN201280006526.XA patent/CN103459419B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505061A5 (enExample) | ||
| JP2015512386A5 (enExample) | ||
| JP5969457B2 (ja) | 化合物およびそれらの使用 | |
| JP2017518370A5 (enExample) | ||
| NZ713202A (en) | Diagnosis and treatments relating to th2 inhibition | |
| RU2013139294A (ru) | Новые синтетические пептиды и их применение | |
| JP2013520405A5 (enExample) | ||
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| RU2014145534A (ru) | Пробиотические бактерии | |
| WO2009046824A3 (en) | Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis | |
| WO2009033782A3 (en) | Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis | |
| WO2011013979A3 (ko) | 봉독을 유효성분으로 하는 여드름 예방 및 치료용 조성물 | |
| EA032951B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| RU2017127273A (ru) | Короткие антимикробные липопептиды | |
| JP2018509388A5 (enExample) | ||
| CN102048817A (zh) | 蚊虫叮咬消痒祛毒液 | |
| MX2013000877A (es) | Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd. | |
| HK1203394A1 (en) | Ghrelin receptor agonists for the treatment of achlorhydria | |
| RU2013127673A (ru) | Композиции с антибактериальной и ранозаживляющей активностью | |
| EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
| EA201390487A1 (ru) | Антимикробный белок | |
| WO2011138785A3 (en) | Use of ccl1 in therapy | |
| NZ719321A (en) | Storage stable lyophilized tripeptide formulations | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| Teymouri et al. | The relationship between the skin microbiome and probiotics in the healing of burn injuries |